Core C will provide statistical and informatics support for all four research projects, Core B (Tissue/Histology), the Developmental Research Program, and the Career Development Program. Specifically, members of the Core will: 1) collaborate with investigators on statistical aspects of the design of in vitro and in vivo laboratory-based studies as new data come to light, and perform t)oth exploratory and confirmatory statistical analyses of data from key experiments;2) perform statistical analyses of single nucleotide polymorphisms (SNPs) and haplotypes in relation to the risk of disease progression and disease-specific survival in SCCHN patients;3) collaborate with basic scientists and clinicians in writing protocols for SPORE-supported clinical trials that are methodologically sound from a statistical perspective, and that will pass scientific, ethical, and regulatory review;4) perform interim analyses of safety for the SPORE-related clinical trials that are underway, and final analyses of the data relating to safety, efficacy, and correlative studies;5) contribute to the review of developmental research proposals, and provide statistical and informatics support for those that are funded;6) maintain and enhance a virtual repository that integrates data from clinical, questionnaire, pathologic, and molecular systems into a single architecture supported by a set of common data elements to facilitate basic-science, clinical, and translational research by the SPORE;7) work with project investigators and UPCI Clinical Research Services to ensure that requisite data are properly recorded for statistical analyses, and that systems for quality assurance and quality control for SPORE-related data are in place;8) continue the development of data-entry, data-mining and data-analysis tools, and a data warehouse for genomic and proteomic data;9) using recorded data elements in the SPORE'S organ-specific database, develop algorithms for study variables that are widely applicable to the SPORE, such as disease progression and recurrence, occurrence of a second primary, treatment with cetuximab, and use of platinum-based treatment regimens;and 10) collaborate with project investigators in writing and preparing progress reports, abstracts, manuscripts, and presentations.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-GRB-I)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
United States
Zip Code
Ledgerwood, Levi G; Kumar, Dhruv; Eterovic, Agda Karina et al. (2016) The degree of intratumor mutational heterogeneity varies by primary tumor sub-site. Oncotarget 7:27185-98
Wen, Yihui; Li, Hua; Zeng, Yan et al. (2016) MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin. Oncotarget 7:23300-11
Lang Kuhs, Krystle A; Pawlita, Michael; Gibson, Sandra P et al. (2016) Characterization of human papillomavirus antibodies in individuals with head and neck cancer. Cancer Epidemiol 42:46-52
Kiesel, Brian F; Parise, Robert A; Guo, Jianxia et al. (2016) Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation. Cancer Chemother Pharmacol 78:1225-1235
Lesseur, Corina; Diergaarde, Brenda; Olshan, Andrew F et al. (2016) Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet 48:1544-1550
Scharping, Nicole E; Menk, Ashley V; Moreci, Rebecca S et al. (2016) The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Immunity 45:374-88
Trivedi, Sumita; Rosen, Clark A; Ferris, Robert L (2016) Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer. Curr Opin Otolaryngol Head Neck Surg 24:121-7
Walline, Heather M; Carey, Thomas E; Goudsmit, Christine M et al. (2016) High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res :
Chiosea, Simion I; Thompson, Lester D R; Weinreb, Ilan et al. (2016) Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Cancer 122:3136-3144
Li, Hua; Wheeler, Sarah; Park, Yongseok et al. (2016) Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts. Mol Cancer Res 14:278-86

Showing the most recent 10 out of 246 publications